Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 9,247

Longevity investor and visionary Sergey Young, founder of Longevity Vision Fund and Innovation Board Member of XPRIZE Foundation, delivers “7 Signs of Longevity Revolution” keynote at Barclay’s recent “Accelerating Evolution” conference, discussing recent developments in the longevity industry.

Watch to find out the forecasts for the industry’s trajectory of growth in the coming years, the increasing emergence of practical, real-world applications in the longevity sphere and how Longevity Vision Fund striving to be on the very forefront of the ongoing Longevity Revolution that is already happening around us today.

#longevity #lvf #longevityvisionfund #lifeextension #longevityrevolution #sergeyyoung #barclays

Read more | >

The art of tattooing may have found a diagnostic twist. A team of scientists in Germany have developed permanent dermal sensors that can be applied as artistic tattoos. As detailed in the journal Angewandte Chemie, a colorimetric analytic formulation was injected into the skin instead of tattoo ink. The pigmented skin areas varied their color when blood pH or other health indicators changed.

Read more | >

Researchers from the Beijing Institute of Brain Disorders have discovered a new method of using exosomes to deliver aptamers that prevent the accumulation of α-synuclein aggregates, which are the cause of Parkinson’s disease [1].

α-Synuclein Aggregates

Like Alzheimer’s, Parkinson’s disease is characterized by protein aggregation caused by a loss of proteostasis, one of the hallmarks of aging. In order for the brain to function properly, non-aggregated α-synuclein proteins are needed in order to facilitate the release of dopamine, a neurotransmitter, in nerve cell synapses. α-synuclein only becomes a problem when proteostasis fails and the proteins misfold, aggregate, and accumulate.

Read more | >